TapRooT® for Pharmaceuticals

Quality, Safety, and Regulatory Compliance is Essential to Pharmaceutical Company Performance

A warning letter from the FDA, a disabled employee, or product recall can be prevented with advanced root cause analysis

Applying advanced root cause analysis – TapRooT® – can help you improve performance by investigating quality issues and proactively preventing problems. You can’t afford failed corrective actions from common root cause analysis. Instead, choose TapRooT® advanced root cause analysis.

Challenges:

• Avoid warning letters from the FDA.
• Effective root cause analysis of any out of specification incident.
• Quality process excellence.
• Reduce Lost Time Injuries.
• Process safety compliance.
• Investigating drug safety issues.
• Avoiding drug recalls.
• Manufacturing excellence and improved safety performance.
• Eliminating bacterial contamination, drug mislabeling, premature drug deterioration in the supply pipeline, or out of specification batches.

Download "3 Common CAPA Failures that May Trigger an FDA Warning Letter (and How to Avoid Them)."

First name*

Last name*

Email*

Phone number*

Company name*

Job Title*

Country*